These discoveries lead us to propose a hypothesis that ELAVL1 interacts with HMGB3 to enhance its stability, thereby promoting aerobic glycolysis in nasopharyngeal carcinoma cells by further activating the β-catenin pathway. The gene discussed is ELAVL1; the disease is nasopharyngeal carcinoma.